Stuart Shanler
2015
In 2015, Stuart Shanler earned a total compensation of $2.3M as Chief Scientific Officer at Aclaris Therapeutics, a 368% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $86,250 |
|---|---|
| Option Awards | $1,710,920 |
| Salary | $287,499 |
| Stock Awards | $166,344 |
| Other | $45,278 |
| Total | $2,296,291 |
Shanler received $1.7M in option awards, accounting for 75% of the total pay in 2015.
Shanler also received $86.3K in non-equity incentive plan, $287.5K in salary, $166.3K in stock awards and $45.3K in other compensation.
Rankings
In 2015, Stuart Shanler's compensation ranked 4,200th out of 13,638 executives tracked by ExecPay. In other words, Shanler earned more than 69.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,200 out of 13,638 | 69th |
Division Manufacturing | 1,539 out of 5,190 | 70th |
Major group Chemicals And Allied Products | 560 out of 1,854 | 70th |
Industry group Drugs | 443 out of 1,528 | 71st |
Industry Pharmaceutical Preparations | 348 out of 1,182 | 71st |
Source: SEC filing on May 20, 2016.
Shanler's colleagues
We found two more compensation records of executives who worked with Stuart Shanler at Aclaris Therapeutics in 2015.